Contact:
VP
Investor Relations
T: +61 419 548 434
E: lisa.pendlebury@maynepharma.com
About
(C) 2021 Electronic News Publishing, source
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.98 AUD | -1.83% | -1.97% | +13.50% |
26/02 | Mayne Pharma Group Swings to Loss in Fiscal H1 Despite Revenue Growth; Shares Jump 15% | MT |
25/02 | Transcript : Mayne Pharma Group Limited, H1 2024 Earnings Call, Feb 26, 2024 |
Contact:
VP
Investor Relations
T: +61 419 548 434
E: lisa.pendlebury@maynepharma.com
About
(C) 2021 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
+13.50% | 367M | |
+20.81% | 43.34B | |
+20.89% | 21.96B | |
+13.30% | 14.09B | |
+12.97% | 13.64B | |
+39.74% | 11.43B | |
-10.06% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+9.64% | 5.22B |